Market Views – Page 26 – media

China’s success–first human implantation of a retrievable transcatheter aortic valve

Prof. Wang Jian'an, president of SAHZU, announced that China has completed its first successful human implantation of a retrievable transcatheter aortic valve.
- Source: biospectrumasia
- 508
- December 1, 2017
aortic valve cardiac implantation Market Views transcatheter
metaLinear Secures 255K Pound Seed Investment for Targeted Antibacterial Research

MetaLinear is a start-up biotechnology company founded in 2017, focused on the identification and validation of new drug targets for difficult to treat bacterial infections. The new investment was secured from the BioCity Group Ltd, who manage the Alderley Park Ventures (APV) fund and Catapult Ventures, who manage the Greater Manchester and Cheshire (GM&C) Life Sciences Fund. Both funds look to back innovative, high-technology companies providing much needed early stage finance.
- Source: biocity.co.uk;
- 475
- December 1, 2017
bacterial infections Market Views new drug
Synpromics Announces Collaboration with UCL to Develop Revolutionary Gene Therapy for Parkinson’s Disease

Synpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system (CNS), to develop a gene therapy for Parkinson’s disease.
- Source: Businesswire
- 472
- November 30, 2017
CNS Market Views Parkinson’s disease
Codiak BioSciences Closes $76.5 Million Series C Financing

Codiak intends to use the proceeds of the Series C financing to advance its initial product candidates into clinical trials, and to continue to develop the company's transformational exosome therapeutic platform.
- Source: Businessinsider
- 597
- November 30, 2017
Clinical Trials exosome therapeutic Market Views Series
Doctolib raises another $42 million for its medical care scheduling service

French startup Doctolib is raising money for the second time in the past twelve months. The company is building a sort of Salesforce for the healthcare industry with a big emphasis on bookings. Doctolib just raised $42 million (€35 million) from Eurazeo and existing investor Bpifrance.
- Source: Technologythrill
- 457
- November 29, 2017
Doctolib Market Views Series
Biogen and Alkermes Announce License and Collaboration Agreement to Develop and Commercialize ALKS 8700 for the Treatment of Multiple Sclerosis

Biogen (Nasdaq:BIIB) and Alkermes plc (Nasdaq:ALKS) today announced that they have entered into a global license and collaboration agreement to develop and commercialize ALKS 8700, a novel, oral, monomethyl fumarate (MMF) small drug molecule in Phase 3 development for the treatment of relapsing forms of multiple sclerosis (MS).
- Source: businesswire
- 506
- November 29, 2017
ALKS 8700 Biogen Market Views
Bay Area’s Medeor Therapeutics Bags $57M

Medeor Therapeutics announced it had closed on an oversubscribed Series B financing worth $57 million. The round was led by RA Capital Management. New investors included Sofinnova Ventures and 6 Dimensions Capital. They were joined by existing investors Vivo Capital and WuXi Healthcare Ventures.
- Source: Biospace
- 618
- November 28, 2017
cellular immunotherapies Market Views Series
How can you cope with seasonal affective disorder?

Seasonal affective disorder (SAD) is a type of depression that comes and goes with the four seasons, typically manifesting during the cold autumn and winter months, when the days are shorter, darker, and chillier.
- Source: medicalnewstoday
- 402
- November 27, 2017
Market Views SAD Seasonal affective disorder
European Commission Approves TREMFYA® (guselkumab) for the Treatment of Moderate to Severe Plaque Psoriasis in the European Union

Janssen-Cilag International NV announced that the European Commission (EC) has approved TREMFYA® (guselkumab) for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy. Guselkumab is the first biologic that selectively blocks interleukin (IL)-23, a key driver of the immune inflammatory response in psoriasis.
- Source: Prnewswire
- 460
- November 27, 2017
interleukin Market Views plaque psoriasis TREMFYA
Massachusetts’ Entasis Snags $31.9 Million To Advance Anti-infective Therapeutic Portfolio

“We welcome this strong support from a group of experienced and successful investors who understand the need and market opportunity for new medicines to combat multi drug-resistant bacterial infections”
- Source: biospace
- 482
- November 23, 2017
anti-infective drug-resistant Gram-negative infections Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.